
|Videos|November 10, 2022
Update on adjuvant treatment of bladder cancer
Author(s)Urology Times staff
“The bar is high; we want to be curing these patients, not just delaying a recurrence of their cancer,” says Arlene O. Siefker-Radtke, MD.
Advertisement
In this video, Arlene O. Siefker-Radtke, MD, discusses recent developments in the adjuvant treatment of bladder cancer. Siefker-Radtke is a professor of Genitourinary Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston. She was interviewed at the
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
3
Pearls & Perspectives: Expanding Options for Men With Erectile Dysfunction, With Tom Riester
4
RAD-IO: Durvalumab plus chemoradiotherapy is feasible in MIBC
5











